Euprotec was acquired by Evotec in 2014.
Euprotec is a world leader in the provision of infectious disease biology services and offers an extensive and highly validated portfolio of efficacy and disease models. Underpinned by internationally recognized scientific expertise and a full range of microbiology, PKPD, and DMPK capabilities; we support each stage of our clients’ anti-infective drug discovery and development programs through to late stage preclinical investigation and clinical proof-of-concept studies.